Refractory myasthenia gravis exacerbation triggered By pembrolizumab

Saved in:
Bibliographic Details
Published in:Muscle & nerve 2018-04, Vol.57 (4), p.E120-E121
Main Authors: Earl, Damien E., Loochtan, Aaron I., Bedlack, Richard S.
Format: Article
Language:English
Subjects:
exacerbation
immune checkpoint inhibitor
immune‐related adverse event
Immunotherapy
melanoma
Monoclonal antibodies
Myasthenia
Myasthenia gravis
Neuromuscular junctions
pembrolizumab
Targeted cancer therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0148-639X
1097-4598
DOI:10.1002/mus.26021